Coding With Fun
Home Docker Django Node.js Articles Python pip guide FAQ Policy

Is the acvrl1 c.314-35a > g polymorphism a hereditary polymorphism?


Asked by Leighton Mack on Dec 09, 2021 FAQ



The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
In respect to this,
The mutation of ACVRL1 gene is the pathogenic gene of this family. The SNPs of the rs6435156 and rs1048829 locus in the BMPR2 gene, the rs121909287 loci in the ACVRL1 gene, and the rs397514716 locus in the SMAD9 gene were associated with a risk of essential hypertension (EH) in Han Chinese.
Furthermore, A novel intron mutation in ACVRL1 gene is associated with familial hereditary hemorrhagic telangiectasia. The balance in signalling through either ALK-1 or ALK-5 regulates leptin expression in mesenchymal stem cells. ACVRL1 gene expression is significantly corellated with advanced tumor stages and it is a useful marker for prognosis.
And,
Mutations in ACVRL1 gene is not associated with pulmonary arterial hypertension. In chronic subdural hematomas, the expression of ALK-1 was slightly increased in the dura and markedly up-regulated in the outer membrane. P7170 inhibited the phosphorylation of AKT1.
Moreover,
ENG mutation carriers were more likely than ACVRL1 mutation carriers to have pAVMs (P < 0.001) or multiple lesions (P = 0.03), and to undergo procedural intervention (P = 0.02). The HHT severity score was significantly higher in ENG than in ACVRL1 (P = 0.02).